Exane Derivatives’s Revvity RVTY Stock Holding History

Exane Derivatives’s Portfolio RVTY Stock Details RVTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3.27K	Sell	23 -722	-97%	-$108K	﹤0.01%	408
2022 Q1	$130K	Sell	745 -190	-20%	-$33.8K	0.04%	430
2021 Q4	$188K	Sell	935 -279	-23%	-$50.4K	0.05%	345
2021 Q3	$210K	Sell	1,214 -200	-14%	-$35.2K	0.05%	384
2021 Q2	$217K	Sell	1,414 -454	-24%	-$63.8K	0.05%	375
2021 Q1	$240K	Sell	1,868 -787	-30%	-$109K	0.07%	274
2020 Q4	$381K	Buy	+2,655	New	+$353K	0.11%	214

Other funds holding RVTY

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Exane Derivatives's RVTY Position: Q2 2022 in Review

Exane Derivatives reduced its Revvity (RVTY) stake by 97% in Q2 2022, selling an estimated $108K and leaving 23 shares worth $3.27K. The position accounts for ﹤0.01% of the portfolio, ranked #408.

Exane Derivatives first reported a position in RVTY in Q4 2020 and has held it in 7 quarters since. The position peaked at $381K in Q4 2020. 584 funds tracked by Wall St. Rank hold RVTY as of Q2 2022.

Exane Derivatives held 23 shares of Revvity worth $3.27K as of Q2 2022.
Exane Derivatives sold 722 Revvity shares in Q2 2022, an estimated $108K.
Revvity made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #408 holding.
Exane Derivatives first reported a position in Revvity in Q4 2020 and has held it in 7 quarters since.
Exane Derivatives's Revvity position peaked at $381K in Q4 2020.
584 funds tracked by Wall St. Rank held Revvity as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.